RecruitingNot ApplicableNCT07741656

A Study of the Beacon Platform for Holmium Laser Enucleation of the Prostate (HoLEP)

A Pilot, Prospective, Multicenter, Open-label Study of the Beacon Platform for Holmium Laser Enucleation of the Prostate (HoLEP)

Sponsor

Andromeda Surgical

Enrollment

50 participants

Start Date

Sep 26, 2025

Study Type

INTERVENTIONAL

Conditions

BPH (Benign Prostatic Hyperplasia)HoLEP (Holmium Laser Enucleation of Prostate)

Summary

This single-arm study aims to evaluate the Beacon Platform, an advancement in urological surgery. The study will assess its intraoperative and postoperative outcomes. The aim of this investigation is to establish safety and performance of the Beacon Platform.

Eligibility

Sex: MALEMin Age: 45 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called Beacon Platform for people with bph (benign prostatic hyperplasia) and holep (holmium laser enucleation of prostate). The study is currently recruiting participants at 5 locations. People eligible for this study include men aged 45 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.